4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine
C18H18ClFN6O — CID 53237031
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine
4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine (PubChem CID 53237031) has the molecular formula C18H18ClFN6O and a molecular weight of 388.83 g/mol. Its IUPAC name is 4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine.
Molecular Properties
| Compound Name | 4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine |
|---|---|
| PubChem CID | 53237031 |
| Molecular Formula | C18H18ClFN6O |
| Molecular Weight | 388.83 g/mol |
| Exact Mass | 388.12 |
| IUPAC Name | 4-[4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-amine |
| SMILES | Cc1cc(Cl)cc(OCCn2cc(F)cn2)c1-c1nc(N)nc2c1CNC2 |
| InChI | InChI=1S/C18H18ClFN6O/c1-10-4-11(19)5-15(27-3-2-26-9-12(20)6-23-26)16(10)17-13-7-22-8-14(13)24-18(21)25-17/h4-6,9,22H,2-3,7-8H2,1H3,(H2,21,24,25) |
| InChIKey | CONMCBPVGDTILX-UHFFFAOYSA-N |
| XLogP | 2.71 |
| TPSA | 90.88 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 388.83 |
| LogP ≤ 5 | 2.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53237031 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.